Key PointsWave Life Sciences' shares dropped after its weight loss candidate failed to impress in a phase 1 study.
Is This Weight Loss Drug Stock a Buy on the Dip?
Key PointsWave Life Sciences' shares dropped after its weight loss candidate failed to impress in a phase 1 study.